Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:175

Official publication of the Indian Society of Nephrology
Ahead of Print

Rare, yet emerging cause of graft dysfunction—ALECT 2 amyloidosis

1 Division of Nephrology, Grecian Hospital, Mohali, Punjab, India
2 Department of Histopathology, Core Diagnostics, Gurgaon, Haryana, India
3 Department of Histopathology, Medicos Centre, Chandigarh, India
4 Department of Transplant Surgery, Surya Kidney Hospital, Mohali, Punjab, India

Correspondence Address:
Kulwant Singh,
Division of Nephrology, Grecian Hospital, Sector 69, Mohali - 160 062, Punjab
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijn.IJN_258_19

Amyloidosis is characterized by pathological deposition of abnormal protein aggregates in various tissues, AL protein being the commonest. Amyloidosis derived from leukocyte cell-derived chemotaxin 2 (LECT2) is a recently recognized form of amyloidosis in the United States with predominant involvement of kidney and liver. We present a case of ALECT2 renal amyloid in a transplant recipient who presented with gradual worsening of graft function and subnephrotic proteinuria. To our knowledge, this is first case of LECT2 amyloidosis from Northern India in a transplant recipient. There is no effective therapy for amyloidosis derived from leukocyte cell-derived chemotaxin 2.

Print this article
  Search Pubmed for
    -  Singh K
    -  Sethi J
    -  Duggal R
    -  Joshi K
    -  Bains AS
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded94    

Recommend this journal

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07